tbuckley/cabot-search huggingface dataset:
Clinico-Pathological Spectrum and Role of Flow Cytometry in Myelodysplastic Syndrome: Experience of a Tertiary Care Centre in North India
Authors: Khaliqur Rahman, Ruchi Gupta, Manish Singh, Surabhi Kumari, Geeta Yadav, Pradeep Kumar, Anshul Gupta, Soniya Nityanand
Journal: Blood (2016)
Defining the Primate GvHD Transcriptome: Network Analysis Identifies the Key Pathways Responsible for GvHD Pathogenesis and the Mechanisms of Partial GvHD Control with Sirolimus
Authors: Natalia Kozyr, Carly GK Ziegler, Swetha Ramakrishnan, Aneesah Polnett, Kelly Hamby, Taylor Deane, Linda Stempora, Bruce R. Blazar, Leslie S. Kean
Journal: Blood (2012)
Prospective Isolation of the Earliest Common Myeloid Progenitor in Adult Hematopoiesis
Authors: Kohta Miyawaki, Yojiro Arinobu, Kentaro Kohno, Hirofumi Tsuzuki, Tadafumi Iino, Takahiro Shima, Hiromi Iwasaki, Koichi Akashi
Journal: Blood (2012)
Preclinical Characterization of KB003, a Novel Humaneered™ Monoclonal Anti-GM-CSF Antibody, Demonstrates That the GM-CSF Signaling Axis Is a Therapeutic Target in Chronic Myelomonocytic Leukemia (CMML)
Authors: Eric Padron, Jeffrey S Painter, Adam W Mailloux, Kathy L. McGraw, Jessica M. McDaniel, Christopher Bebbington, Mark Baer, Geoffrey Yarranton, Jeffrey E Lancet, Rami S. Komrokji, Alan F. List, P.K. Epling-Burnette
Journal: Blood (2012)
Chromatin Immunoprecipitation of GFP-Tagged PML-Rara Coupled to High-Throughput Next Generation Sequencing.
Authors: Nicole R. Grieselhuber, Jahangheer S. Shaik, Li-Wei Chang, Sean McGrath, Lukas D. Wartman, Rakesh Nagarajan, Richard K. Wilson, Elaine Mardis, Timothy J. Ley
Journal: Blood (2009)
Comparable Survival and Incidence of Toxicity for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Gunjan L. Shah, Michael Scordo, Satyajit Kosuri, Diego Adrianzen Herrera, Molly A. Maloy, Jimmy Nieves, Sean Devlin, Taylor Borrill, Scott T. Avecilla, Richard C. Meagher, Richard J. O'Reilly, Guenther Koehne, Brian C. Shaffer, Miguel-Angel Perales, Boglarka Gyurkocza, Hugo R. Castro-Malaspina, Sergio A. Giralt, Roni Tamari
Journal: Blood (2016)
Clinical Outcomes and Prognostic Factors of Front-Line Autologous Stem Cell Transplantation in Patients with Extranodal NK/T-Cell Lymphoma
Authors: Ho-Young Yhim, Jin Seok Kim, Yeung-Chul Mun, Chu-Myong Seong, Joon Ho Moon, Yong Park, Jae-Cheol Jo, Seok Jin Kim, Jae-Yong Kwak, Je-Jung Lee, Deok-Hwan Yang
Journal: Blood (2014)
CD32, CD18, CD11b and CD62L Expression on Monocyte without and After Lipopolysaccharide (LPS) Challenge: Association with Inflammatory and Hemolysis Markers In Sickle Cell Anemia.
Authors: Bruno A. V. Cerqueira, Wendell Vilas-Boas, Jose Moura Neto, Jorge Clarencio, Daniela Andrade, Rodrigo Cezar, Angela Zanette, Mitermayer Reis, Marilda Goncalves
Journal: Blood (2010)
mTORC1 Activity Is Independent of PI3K/Akt but Controlled by AMPK in Acute Myeloid Leukemia.
Authors: Alexa Samantha Green, Jerome Tamburini, Lise Willems, Nicolas Chapuis, Sophie Park, Valérie Bardet, Marc Foretz, Benoit Viollet, Norbert Ifrah, Francois Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary
Journal: Blood (2008)
Fractionated ICE with Rituximab Is Safe and Effective for Relapse/Refractory DLBCL Patients with Severe Comorbidities
Authors: Norina Tanaka, Yoichi Imai, Aya Watanabe, Kenjiro Mitsuhashi, Kentaro Yoshinaga, Masayuki Shiseki, Naoki Mori, Junji Tanaka
Journal: Blood (2015)
Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.
Authors: Daniele Laszlo, Giancarlo Pruneri, Giovanna Andreola, Davide Radice, Liliana Calabrese, Alessandra Alietti, Alberto Agazzi, Anna Vanazzi, Giovanni Martinelli
Journal: Blood (2006)
The Impact of the Bone Marrow Microenvironment on T Cell Redirection Therapeutics
Authors: Priyanka Nair-Gupta, Stephen Rudnick, Leopoldo Luistro, Diana Chin, Melissa Smith, Ronan McDaid, Yingzhe Li, Kodandaram Pillarisetti, Eric Baldwin, Kathryn Packman, Yusri Elsayed, Ricardo M. Attar, François Gaudet
Journal: Blood (2016)
Cartridge-Based Automated BCR-ABL mRNA Quantification: Towards Simplified Standardisation.
Authors: Jean-Michel Cayuela, Elizabeth Macintyre, Meryl Darlington, Raouf Ben Abdelali, Xavier Fund, Patrick Villarèse, William Piterboth, Michel Tulliez, Emmanuel Raffoux, Francois Sigaux, Delphine Rea, Dominique Bories, Valerie Seror
Journal: Blood (2009)
Pediatric-Based Therapy for Young Adults with Newly Diagnosed Lymphoblastic Leukemia.
Authors: Michael Rytting, Deborah A. Thomas, Anna R Franklin, Elias Jabbour, William Wierda, Stefan Faderl, Robert Wells, Tapan Kadia, Farhad Ravandi, Alessandra Ferrajoli, Jorge Cortes, Susan O'Brien, Hagop Kantarjian
Journal: Blood (2009)
Enhancing Activity of Bortezomib Against Multiple Myeloma (MM) through Inhibition of Interleukin (IL)-6 Signaling: A Role for Repression of Myeloid Cell Leukemia (Mcl)-1.
Authors: Peter M. Voorhees, George W. Small, Deborah J. Kuhn, Qing Chen, Sally A. Hunsucker, Robert Corringham, Carlos A. Garay, Mohamed H. Zaki, Jeffrey Nemeth, Robert Z. Orlowski
Journal: Blood (2006)
Targeting MALT1 with the Small Molecule Inhibitor MI2 Induces a Caspase-Dependent Apoptosis and Inhibits the NF-κb Pathway in Chronic Lymphocytic Leukemia Primary Cells
Authors: Georges Tanios, Patricia Lobelle-Rich, Ashwin Vasudevamurthy, Thomas S. Atkinson, Ali Baghian, Delong Liu, Hana Safah, Erik K. Flemington, Nakhle S. Saba
Journal: Blood (2016)
Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes – Single Institution Experience
Authors: Grzegorz S. Nowakowski, Kay Ristow, Paul Kurtin, Mark S Allen, Ivana N Micallef, Joseph Colgan, David James Inwards, Ellen McPhail, Svetomir Markovic, Stephen M. Ansell, Luis Porrata, Patrick B Johnston, Carrie A Thompson, Thomas E. Witzig, Thomas M. Habermann
Journal: Blood (2010)
Increased Von Willebrand Factor and High Circulating Placental Growth Factor Correlate with Inflammation and Iron Overload in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia
Authors: Ersi Voskaridou, Katerina Larrisi, Marianna Politou, Veroniki Komninaka, Filia Apostolakou, Chrysanthi Skevaki, Maria Giannaki, Ioannis Papassotiriou, Evangelos Terpos
Journal: Blood (2014)
The EphrinB2/EphB4 Axis Is Dysregulated in Osteoprogenitors from Myeloma Patients and Its Activation by EphrinB2-Fc or EhpB4-Fc Affects Myeloma Bone Disease and Tumor Growth in Vivo
Authors: Angela Pennisi, Wen Ling, Xin Li, Jianmei Chen, Sharmin Khan, Shmuel Yaccoby
Journal: Blood (2008)
RUNX3 Promotes the Development of MDS/MPN Overlap Syndrome Via Enhancing Expression of Myc in the Absence of Tet2
Authors: Takako Yokomizo, Daiki Tanaka, Sho Kubota, Motohiko Oshima, Yuka Harada, Akinori Kanai, Atsushi Iwama, Hironori Harada, Motomi Osato, Goro Sashida
Journal: Blood (2017)
Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism In Acutely Ill Medical Patients: MAGELLAN Study Methodology
Authors: Alexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, Lloyd Haskell, Da-Yi Hu, Russell Hull, Alexandre Mebazaa, Geno Merli, Sebastian Schellong, Alexander Spyropoulos, Victor Tapson
Journal: Blood (2010)
Efficacy and Safety of Peg-Interferon-α2a In Myelofibrosis: a Study of the FIM and GEM French Cooperative Groups
Authors: Jean-Christophe Ianotto, Françoise Boyer-Perrard, Jean-Loup Demory, Jerome Rey, Lydia Roy, Christian Berthou, Brigitte Dupriez, Dana Ranta, Mireille Potard, Michele Schoenwald, Jean-François Abgrall, Jean-Jacques Kiladjian
Journal: Blood (2010)
Validation of the Serial Use of the Myelofibrosis Symptom Assessment Form (MF-SAF) for Measuring Symptomatic Improvement: Performance in 86 Myelofibrosis Patients On INCB018424 Clinical Trial.
Authors: Ruben A. Mesa, Hagop Kantarjian, Ayalew Tefferi, Richard Levy, Kris Vaddi, Susan Erickson-Viitanen, Deborah A. Thomas, Jorge Cortes-Franco, Gautam Borthakur, Animesh D. Pardanani, Zeev Estrov, Srdan Verstovsek
Journal: Blood (2009)
Changes in the Expression of Proteasome Genes in Tumor Cells Following Short-Term Proteasome Inhibitor Therapy Predicts Survival in Multiple Myeloma Treated with Bortezomib-Containing Multi-Agent Chemotherapy
Authors: John D. Shaughnessy, Pingping Qu, Ricky Edmondson, Damir Herman, Yiming Zhou, Erming Tian, Frits van Rhee, Mauricio Pineda-Roman, Yazan Alsayed, Elias Anaissie, Ya-wei Qiang, Joshua Epstein, Shmuel Yaccoby, David Williams, Fenghuang Zhan, Owen Stephens, Antje Hoering, John Crowley, Bart Barlogie
Journal: Blood (2008)
A Comparison of Myelopoiesis from Induced Pluripotent Stem Cells with a Mutation in ELANE between Cyclic Neutropenia and Severe Congenital Neutropenia
Authors: Satoshi Saito, Shiho Nishimura, Miyuki Tsumura, Yoko Mizoguchi, Sonoko Sakata, Aya Furue, Mizuka Miki, Hiroshi Kawaguchi, Takafumi Hiramoto, Yasuhiro Ebihara, Kohichiro Tsuji, Tatsutoshi Nakahata, Masao Kobayashi
Journal: Blood (2015)
The ketogenic diet alters the epigenetic landscape of GBM to potentiate the effects of chemotherapy and radiotherapy
Authors: Qingyu Zeng, Tzouliana Stylianou, Jessica Preston, Sophie Glover, Kevin O’Neill, Eric C Woolf, Adrienne C Scheck, Nelofer Syed
Journal: Neuro-Oncology (2019)

Abstract Glioblastoma Multiforme (GBM) is the most aggressive form of primary brain tumour, with a median survival of 12–14 months after diagnosis. Although GBM has been extensively characterised on the molecular level during the past decades, many targeted therapies have been proved to be ineffective due to high heterogeneity of GBM. Thus, novel therapies targeting the altered metabolism which is exhibited by all cancer cells have gained more attentions. Our strategy is the therapeutic ketogenic diet (KD), a high fat, low carbohydrate and adequate protein diet, which has been recognized as a treatment for refractory paediatric epilepsy. Recent studies have shown that KD reduces tumour growth and potentiates the effects of radiotherapy in some glioma animal models. However, the underlying mechanism is still unclear. To unravel the mechanism of action, we carried out small-RNA sequencing and chromatin modifying enzyme analysis using brain tumour samples from GBM mice model, fed with either KD or standard diet (SD). Our results highlighted an overall upregulation of tumour suppressor miRNAs and key chromatin modifying enzymes that are typically downregulated in GBM in mice fed with KD compared with those fed with SD. We also observed a corresponding downregulation in target genes of these miRNAs and chromatin modifying enzymes. These genes have been reported as key regulators in tumour growth, tumour invasion and chemo/radio-resistance in previous publications. Therefore, our study indicates that targeting cancer metabolism using the KD alters the epigenetic landscape of GBM and induces changes in key genes that potentiate the effects of chemo/radiotherapy.
Regulating heart repair with cardiac-specific T lymphocytes
Authors: Ziad Mallat
Journal: Journal of Clinical Investigation (2019)

Cardiac tissue necrosis secondary to coronary artery occlusion is one of the most common and deadly sterile injuries in developed countries. In this issue of the JCI, Rieckmann et al. identified and characterized antigen-specific CD4+ T helper (Th) cells that developed in the context of myocardial infarction (MI) in mice. They showed that myosin heavy chain α (MYHCA) is a dominant cardiac autoantigen and that T cells with T cell receptor (TCR) specificity to MYHCA acquired a Treg phenotype when adoptively transferred into infarcted mice, which mediated a cardioprotective healing response. Thus, Rieckmann et al. showed that an acute ischemic insult to the heart, which induces sterile inflammation, promoted, rather than limited, protective T cell autoimmunity. Notably, strategies that support an antigen-specific Treg response may limit the immune-inflammatory response and promote cardiac repair after acute MI.
A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis
Authors: Karen Dybkær, Martin Bøgsted, Steffen Falgreen, Malene Krag Kjeldsen, Alexander Schmitz, Julie Støve Bødker, Anders Ellern Bilgrau, Zijun Y. Xu-Monette, Li Ling, Kim Steve Bergkvist, Maria Bach Laursen, Maria Rodrigo-Domingo, Sara Correia Marques, Sophie Bech Rasmussen, Mette Nyegaard, Michael Gaihede, Michael B. Møller, Richard Samworth, Rajen Shah, Preben Johansen, Tarec Christoffer El-Galaly, Ken H. Young, Hans Erik Johnsen
Journal: Blood (2014)
A Modified Foamy Viral Envelope Enhances Gene Transfer Efficiency and Reduces Toxicity of Lentiviral FANCA Vectors in Fanca-/- HSCs.
Authors: Zejin Sun, Yan Li, Jingling Li, Shanbao Cai, Yi Zeng, Dirk Lindemann, Karen E Pollok, Helmut Hanenberg, D. Wade Clapp
Journal: Blood (2009)
Glioblastoma multiforme in patients over 65 – should we operate?
Authors: Igor Maleyko, Benjamin Hall, Andrew Brodbelt, David Lawson, Michael Jenkinson, Emmanuel Chavredakis
Journal: Neuro-Oncology (2019)

Abstract Aim Current standard of care for glioblastoma is maximum safe resection followed by radio chemotherapy with Temozolomide. Older patients are less likely to receive the full treatment. The aim was to determine treatment and outcomes in glioblastoma patients &gt;65 years. Methods Single centre retrospective study from 2001–2016. Eligible patients had: (i) diagnosis of glioblastoma (ii) undergone biopsy or resection with radiotherapy ± adjuvant chemotherapy. Age at diagnosis, type of surgery, performance status, complications, adjuvant therapy and median survival (MS) were recorded. Patients were assigned to group A (age &lt;65), B (age 65–69 years) or C (age &gt;/= 70 years). Results 637 patients met the eligibility criteria and 403 had complete records for analysis. Age distribution of the cohort was 17.9 – 91.6 years. In the group A (n=259), those who had undergone resection had significantly longer MS compared to biopsy: 17.2 vs 13.2 months (P&lt;0.05 CI: 444.043 – 561.957). 70 patients developed complications. In the group B (n=79), those who had undergone resection had significantly longer MS compared to biopsy: 12.3 vs 5.1 months (P&lt;0.05 CI: 194.354 – 335.646). 17 patients developed complications. In the group C (n=64), analysis did not show statistically significant difference (P=0.066 CI: 220.476 – 321.524). Clinically, patients who had resection had longer MS (10.5 months vs 3.5 months). Furthermore, there was no significant difference in the rate of complications between resection and biopsy (Fisher’s exact test, P=0.755). Conclusion i) Patients &gt;65 should be treated as per the Stupp protocol ii) In patients &gt;70 surgical resection should be considered.:
Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography
Authors: Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, Walter Jeske, Debra Hoppensteadt, Kazuhisa Tsuruta, Jawed Fareed, Mary Lewis
Journal: Blood (2016)
Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Authors: Tobia Lana, Paola de Lorenzo, Silvia Bresolin, Ilaria Bronzini, Monique L. Den Boer, Helene Cave, Eva Fronkova, Martin Stanulla, Marketa Zaliova, Christine J. Harrison, Hester de Groot-Kruseman, Claire Schwab, Maria Grazia Valsecchi, Andrea Biondi, Giuseppe Basso, Giovanni Cazzaniga, Geertruy te Kronnie
Journal: Blood (2014)
A 2-Stage Phase II Study of Panobinostat Consolidation in Multiple Myeloma (MM) Patients with &lt; CR Following Single High-Dose Chemotherapy (HDT) Conditioned Autologous Stem Cell Transplantation (ASCT) As Part of First Line Therapy
Authors: Anna Kalff, Sridurga Mithraprabhu, Tiffany T. Khong, Malarmathy Ramachandran, Kate Reed, Hang Quach, Patricia A. Walker, Krystal Bergin, Andrew Spencer
Journal: Blood (2016)
Aurora A Kinase Is a Novel Therapeutic Target In The Myeloproliferative Neoplasms
Authors: Qiang Jeremy Wen, Benjamin Goldenson, Sebastien Malinge, Brady L Stein, Terra L Lasho, Lawrence Breyfogle, Rachael Schultz, Qiong Yang, Laure gilles-Gendre, Priya Koppikar, Omar Abdel-Wahab, Benjamin L. Ebert, Animesh Pardanani, Sandeep Gurbuxani, Ross L. Levine, Ann Mullally, Ayalew Tefferi, John D Crispino
Journal: Blood (2013)
A Phase I/II Study of Atacicept (TACI-Ig) To Neutralize APRIL and BLyS in Patients with Refractory or Relapsed Multiple Myeloma (MM) or Active Previously Treated Waldenstrom’s Macroglobulinemia (WM).
Authors: Jean-Francois Rossi, Jerome Moreaux, Mikaelle Rose, Marie Picard, Arnaud Ythier, Ciara Rossier, Eric Sievers, Bernard Klein
Journal: Blood (2006)
TREG and Tcon Dynamics after Allo-HSCT: Cgvhd Is Associated to Decreased NaïVe and Stem Cell Memory Subsets with a Concomitant Increase in Terminally Differentiated T Cell Subsets
Authors: Maria V.D. Soares, Rita I Azevedo, Ines A Ferreira, Sara Ventura Bucar, Ana Cristina Alho, Eduardo L Espada, Juncal Clara, Nadia Camacho, Carlos M. Martins, José A Carmo, Fernanda Lourenço, Raul Moreno, Carlos Vaz, Antonio M. Campos, Fernando Campilho, Rosa Ferreira, Jerome Ritz, Joao F Lacerda
Journal: Blood (2016)
Comparison of Fluorescence in Situ Hybridization (FISH) for EVI1 Rearrangement (3q26) and G-Banding in Patients with Acute Myeloid Leukemia with Inv(3) or t(3;3).
Authors: Qute Choi, Dong Soon Lee, Sung-Soo Yoon, Sang Mee Hwang, Seon Young Kim, Jung Ah Kim, Cha Ja She, Jung Eun Choi, Eun Jung Lee, Jiseok Kwon
Journal: Blood (2012)
An Open-Label Study of CEP-701 in Patients with JAK2 V617F-Positive PV and ET: Update of 39 Enrolled Patients.
Authors: Alison R Moliterno, Elizabeth Hexner, Gail J. Roboz, Martin Carroll, Selina Luger, John Mascarenhas, Ronald Hoffman, Debra M Bensen-Kennedy
Journal: Blood (2009)
Prediction of Relapse and Impact of Immunomodulation Based On Quantitative RT-PCR of Insertion/Deletion Polymorphism for Chimerism Analysis in Acute Leukemia
Authors: Nathalie Jacque, Stephanie Nguyen, Jean Louis Golmard, Alice Garnier, Madalina Uzunov, Veronique Leblond, Jean Paul Vernant, Dominique Bories, Nathalie Dhedin
Journal: Blood (2012)
JS-K, a Novel Nitric Oxide (NO) Generator, Induces Cytochrome c Release and Caspase Activation in HL-60 Myeloid Leukemia Cells.
Authors: Paul J. Shami, Vidya Udupi, Margaret Yu, Swati Malaviya, Joseph E. Saavedra, Larry K. Keefer
Journal: Blood (2004)
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Authors: Guangchuan Wang, Ryan D. Chow, Zhigang Bai, Lvyun Zhu, Youssef Errami, Xiaoyun Dai, Matthew B. Dong, Lupeng Ye, Xiaoya Zhang, Paul A. Renauer, Jonathan J. Park, Li Shen, Hanghui Ye, Charles S. Fuchs, Sidi Chen
Journal: Nature Immunology (2019)
Podocalyxin Negatively Regulates Stress Myelopoiesis, Directly Binds Rap-1A and Modulates Its G-CSF-Induced Activity
Authors: Pan Li, Rose McGlauflin, Amanda J Favreau, Edward Jachimowicz, Calvin Vary, Kailin Xu, Don M Wojchowski, Pradeep Sathyanarayana
Journal: Blood (2015)
Accuracy of Magnetic Resonance Direct Thrombus Imaging (MRDTI) As a Novel Tool in the Diagnosis of Acute Ipsilateral Recurrent Deep Vein Thrombosis
Authors: Melanie Tan, Gerben C Mol, Marcel A Van de Ree, Cornelis J Van Rooden, Robin E Westerbeek, Antonio Iglesias del Sol, Albert de Roos, Menno V. Huisman
Journal: Blood (2012)
Safety of Deferasirox (Exjade®) in Myelodysplastic Syndromes (MDS) and Non-MDS Patients with Transfusional Iron Overload: A Pooled Analysis Focusing On Renal Function.
Authors: Mathias Schmid, M. Domenica Cappellini, John B. Porter, Peter L. Greenberg, Tomasz Lawniczek, Sabine Glaser, Victor Dong, Norbert Gattermann
Journal: Blood (2009)
Clinical, Immunologic, and Virologic Findings in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Lymphomas Suggest KSHV-Associated Inflammatory Syndromes Contribute to Symptoms and Disease Pathogenesis.
Authors: Thomas S Uldrick, Mark N Polizzotto, Armando Filie, Karen Aleman, Kathleen M Wyvill, Richard F Little, Seth M. Steinberg, Elaine S Jaffe, Denise Whitby, Stefania Pittaluga, Robert Yarchoan
Journal: Blood (2012)
Forodesine, a Purine Nucleoside Phosphorylase (PNP) Inhibitor, Shows Clinical Activity In a Phase 2 Trial In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL) – Interim Analysis
Authors: Taimur Sher, Jose Azar, Stephen Spurgeon, John Catalano, Richard R. Furman, Miles Prince, Nancy L. Bartlett, Simon Durrant, Ralph Boccia, Aisha Masood, Scott Lyman, Jean Cantey-Kiser, William P Sheridan, Asher Chanan-Khan
Journal: Blood (2010)
ZAP-70 Expression, VH-Mutation Status, Genomic Aberrations and Prognosis in Chronic Lymphocytic Leukemia.
Authors: Alexander Kröber, Dirk Kienle, Dirk Winkler, Andreas Bühler, Till Seiler, Christine Schöpflin, Sabrina Kless, Claire Paulus, Hartmut Döhner, Stephan Stilgenbauer
Journal: Blood (2004)
Reduction in Healthcare Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia (CML) with Better Adherence to Tyrosine Kinase Inhibitors (TKIs) and Increased Molecular Monitoring Frequency
Authors: Dominick Latremouille-Viau, Annie Guerin, Patrick Gagnon-Sanschagrin, Katherine Dea, Benjamin Cohen, George J Joseph
Journal: Blood (2016)
Negative Prognostic Impact Of High CD33 Expression Is Negated With The Use Of Gemtuzumab Ozogamicin: A Report From The Children’s Oncology Group
Authors: Jessica Pollard, Todd A. Alonzo, Robert B. Gerbing, Susana C Raimondi, Betsy Hirsch, Richard Aplenc, Alan S. Gamis, Michael R. Loken, Soheil Meshinchi
Journal: Blood (2013)
Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Simultaneous Quantification of Midostaurin (PKC412) and Its Two Major Metabolites: A Suitable Tool for the Monitoring of the Drug in Patients Suffering From Advanced Systemic Mastocytosis
Authors: Philippe Bourget, Marie-Olivia Chandesris, Alexandre Amin, Fabrice Vidal, Christophe Merlette, Isabelle Hirsh, Ana Carvalhosa, Agnes Mogenet, Christine Broissand, Bérénice Giraud, Laurent Frenzel, Gandhi Damaj, Olivier Lortholary, Olivier Hermine
Journal: Blood (2012)
Updated Results from a Phase II Study of the Fc Engineered CD19 Antibody MOR208 in Combination with Lenalidomide for Patients with Chronic Lymphocytic Leukemia (CLL) and Richter's Transformation or Ibrutinib for Patients with Ibrutinib-Resistant Clones
Authors: Jennifer A. Woyach, Amy S. Ruppert, Farrukh T. Awan, Jeffrey Jones, Leslie A. Andritsos, Sharon Waymer, Gerard Lozanski, Natarajan Muthusamy, John C. Byrd
Journal: Blood (2016)
Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience
Authors: Eugene E. Zvonkov, Nelly G. Gabeeva, Anna K. Morozova, Olga A. Gavrilina, Anna A. Sidorova, Daria A. Koroleva, Tatiana N. Obukhova, Alla Kovrigina, Elena N. Parovichnikova, Valery G Savchenko
Journal: Blood (2016)
NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL.
Authors: Peter Hillmen, Christopher Pocock, Dena Cohen, Kim Cocks, Hazem A. Sayala, Andy Rawstron, Daniel B. Kennedy, Christopher Fegan, Don W. Milligan, Claire Dearden, Alexandra Smith, Emma Lindop, Andrew R. Pettitt
Journal: Blood (2007)
A Phase 1 Trial of Oral AP24534 in Patients with Refractory Chronic Myeloid Leukemia and Other Hematologic Malignancies: First Results of Safety and Clinical Activity against T315I and Resistant Mutations.
Authors: Jorge Cortes, Moshe Talpaz, Michael Deininger, Neil Shah, Ian W Flinn, Michael J. Mauro, Thomas O'Hare, Natalie Spinos, Simin Hu, Lori Berk, Narayana Narasimhan, Victor M. Rivera, Tim Clackson, Frank Haluska, Hagop M. Kantarjian
Journal: Blood (2009)
Integration of Ex Vivo Drug Testing and in-Depth Molecular Profiling Reveals Oncogenic Signaling Pathways and Novel Therapeutic Strategies for Multiple Myeloma
Authors: Muntasir Mamun Majumder, Raija Silvennoinen, Pekka Antilla, David Tamborero, Samuli Eldfors, Riikka Karjalainen, Heikki Kuusanmäki, Juha Lievonen, Alun Parsons, Minna Suvela, Marjanna Säily, Bhagwan Yadav, Krister Wennerberg, Olli Kallioniemi, Kimmo Porkka, Caroline A Heckman
Journal: Blood (2014)